ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3054% below fair value
$71.44+0.38 (+0.53%)
Close on Nov 13, 2026Market cap $1.64BP/E 13.5Yield –
ANI Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
ANI Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was 16.0%. For fiscal 2025 it was 12.6%, against 0.1% the year before. The highest annual figure on record is 42.8% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.6% | +12.5 |
| FY2024 | Dec 31, 2024 | 0.1% | −9.6 |
| FY2023 | Dec 31, 2023 | 9.6% | +20.8 |
| FY2022 | Dec 31, 2022 | -11.2% | +7.3 |
| FY2021 | Dec 31, 2021 | -18.4% | −10.7 |
| FY2020 | Dec 31, 2020 | -7.7% | −15.6 |
| FY2019 | Dec 31, 2019 | 7.9% | −9.6 |
| FY2018 | Dec 31, 2018 | 17.5% | +1.5 |
| FY2017 | Dec 31, 2017 | 16.0% | +0.4 |
| FY2016 | Dec 31, 2016 | 15.6% | −27.2 |
| FY2015 | Dec 31, 2015 | 42.8% | +7.1 |
| FY2014 | Dec 31, 2014 | 35.7% | +32.8 |
| FY2013 | Dec 31, 2013 | 3.0% | +3.2 |
| FY2012 | Dec 31, 2012 | -0.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 18.0% | +2.1 |
| Q2 FY2026 | Jun 30, 2026 | 15.2% | +8.6 |
| Q1 FY2026 | Mar 31, 2026 | 16.4% | +3.1 |
| Q4 FY2025 | Dec 31, 2025 | 14.1% | +16.4 |
| Q3 FY2025 | Sep 30, 2025 | 15.9% | +29.7 |
| Q2 FY2025 | Jun 30, 2025 | 6.6% | +2.8 |
| Q1 FY2025 | Mar 31, 2025 | 13.3% | −1.5 |
| Q4 FY2024 | Dec 31, 2024 | -2.3% | −7.4 |
| Q3 FY2024 | Sep 30, 2024 | -13.8% | −27.4 |
| Q2 FY2024 | Jun 30, 2024 | 3.7% | −6.9 |
| Q1 FY2024 | Mar 31, 2024 | 14.8% | +5.5 |
| Q4 FY2023 | Dec 31, 2023 | 5.1% | +3.2 |
| Q3 FY2023 | Sep 30, 2023 | 13.6% | +19.6 |
| Q2 FY2023 | Jun 30, 2023 | 10.6% | +28.1 |
| Q1 FY2023 | Mar 31, 2023 | 9.3% | +39.0 |
| Q4 FY2022 | Dec 31, 2022 | 1.9% | +40.9 |
| Q3 FY2022 | Sep 30, 2022 | -6.0% | +0.9 |
| Q2 FY2022 | Jun 30, 2022 | -17.5% | +14.5 |
| Q1 FY2022 | Mar 31, 2022 | -29.8% | −35.4 |
| Q4 FY2021 | Dec 31, 2021 | -38.9% | −39.5 |
| Q3 FY2021 | Sep 30, 2021 | -6.8% | −12.1 |
| Q2 FY2021 | Jun 30, 2021 | -32.0% | −8.7 |
| Q1 FY2021 | Mar 31, 2021 | 5.6% | +21.3 |
| Q4 FY2020 | Dec 31, 2020 | 0.6% | +10.3 |
| Q3 FY2020 | Sep 30, 2020 | 5.3% | −9.0 |
| Q2 FY2020 | Jun 30, 2020 | -23.3% | −40.4 |
| Q1 FY2020 | Mar 31, 2020 | -15.8% | −24.1 |
| Q4 FY2019 | Dec 31, 2019 | -9.7% | −29.8 |
| Q3 FY2019 | Sep 30, 2019 | 14.3% | −5.7 |
| Q2 FY2019 | Jun 30, 2019 | 17.1% | +1.7 |
| Q1 FY2019 | Mar 31, 2019 | 8.3% | −5.7 |
| Q4 FY2018 | Dec 31, 2018 | 20.0% | +4.4 |
| Q3 FY2018 | Sep 30, 2018 | 19.9% | +0.6 |
| Q2 FY2018 | Jun 30, 2018 | 15.4% | −0.3 |
| Q1 FY2018 | Mar 31, 2018 | 14.1% | +1.4 |
| Q4 FY2017 | Dec 31, 2017 | 15.6% | +12.2 |
| Q3 FY2017 | Sep 30, 2017 | 19.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 15.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 12.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 3.4% | – |
See a number that looks wrong?